MBS About US

PowerPoint Presentation

Define Your Goal, Let MBS Create the Strategy

Your Partner in Antibody DevelopmentThe central focus of MBSs experienced technical team is understanding customer goals and developing strategies to achieve success, even for the most complex projects. For over 25 years, antibody development has been the core competency of Maine Biotechnology Services.

Expert Project ManagementThe key to a successful and timely antibody development is a goal-focused plan. MBS offers comprehensive project planning and management.Antigen analysis and sourcingRecombinant production capabilitiesEvaluation of reagents, strategies, and timelinesProject plan delivered to the customer

Monoclonal Antibody Development28 Day immunization protocolEarly, refined clone selectionFit-for-purpose screeningTechnical support at every phaseMBS brings expertise, creativity and flexibility to developing a strategy for any antibody development project.

Polyclonal Antibody Development

Polyclonal Antibody Development is offered as a stand alone service or as a compliment to a larger monoclonal or assay development goal set. Rabbits, goats, sheep, and llamasLarge or small scaleCustom purification plans

Antibody Production and PurificationMBS offers seamless transition from antibody development into production, saving time and cost. In vitro or In vivo cGMP certified productionsCustomizable schedulesWide range of purification services

Assay ServicesLet MBS fill the gap between hybridoma screening and final antibody selections with your assay in mind. SpecificitySensitivityMatched pair characterizationMatrix compatibility

Antibody ProductsThe MBS expertise, process, and high quality standard have been applied to the development of a well supported catalog of antibodies to meet our customers clinical diagnostic needs

Most Comprehensive Norovirus Panel on the Market

Chikungunya Virus and an Expanding Arbovirus Offering

Currently offering 3 monoclonal antibodies specific to Chikungunya virus. Shown to recognize active virus with no cross reactivity to other viruses of concern. MBS is currently launching a new development project to develop antibodies specific for NS1 of both Dengue Fever and Zika Virus. It is our goal to offer comprehensive panels of differentiating antibodies to these increasingly concerning targets.

No Substitute for Experience

MBS delivers on a complete partnership. Wholly owned and operated in Maine, USA; we welcome the opportunity to discuss your next antibody development.

Bass Drums Track7 Track8 Track9 Track10